PROTENDEL
DEAD

Serial Number

98902088

Owner

NANJING DELOVA BIOTECH CO., LTD.

Attorney

Yue (Robert) Xu

Filing Date

Dec 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PROTENDEL Trademark

Serial Number: 98902088

PROTENDEL is a trademark filed by NANJING DELOVA BIOTECH CO., LTD. on December 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NANJING DELOVA BIOTECH CO., LTD. (4 trademarks)

Room 509, 510, Bldg 3, No. 99 Lize Road
Nanjing, Jiangsu, 211112 , CN

Entity Type: 99

Trademark Details

Filing Date

December 13, 2024

Registration Date

Not Registered

Goods & Services

Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; Medicines made of Chinese traditional medicinal herbs; Chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Pre-filled syringes for medical purposes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients; Medicines for human purposes in the nature of pain relief medications; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Analgesics; Dietetic foods adapted for medical purposes; Medicines for veterinary purposes for the treatment of infectious diseases, viral conditions, skin conditions, pain, and inflammation; First aid kits; First-aid boxes, filled.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 2, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 2, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
NEW APPLICATION ENTERED
Dec 13, 2024 NWAP